Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients

Neuroscience Letters

Volumn 563, Issue , 2014, Pages 51-54

  Hu, Nan ^a   Tan, Meng Shan ^b   Sun, Lei ^a   Jiang, Teng ^c   Wang, Ying Li ^a   Tan, Lin ^a   Zhang, Wei ^a   Yu, Jin Tai ^a,b,c   Tan, Lan ^a,b,c  

^a QINGDAO UNIVERSITY   (China)

^b OCEAN UNIVERSITY OF CHINA   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Biomarker; CD33; Expression; PBMCs

Indexed keywords

ALZHEIMER'S DISEASE; BIOMARKER; CD33; EXPRESSION; PBMCS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; SIALIC ACID BINDING IG-LIKE LECTIN 3;

EID: 84894052033     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.004     Document Type: Article

References (27)

1. Bossu P., Ciaramella A., Salani F., Bizzoni F., Varsi E., Di Iulio F., Giubilei F., Gianni W., Trequattrini A., Moro M.L., Bernardini S., Caltagirone C., Spalletta G. Interleukin-18 produced by peripheral blood cells is increased in Alzheimer's disease and correlates with cognitive impairment. Brain, Behavior, and Immunity 2008, 22:487-492.
2. Bradshaw E.M., Chibnik L.B., Keenan B.T., Ottoboni L., Raj T., Tang A., Rosenkrantz L.L., Imboywa S., Lee M., Von Korff A., Morris M.C., Evans D.A., Johnson K., Sperling R.A., Schneider J.A., Bennett D.A., De Jager P.L. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nature Neuroscience 2013, 16:848-850.
3. Crocker P.R., Paulson J.C., Varki A. Siglecs and their roles in the immune system. Nature Reviews. Immunology 2007, 7:255-266.
4. Crocker P.R., Redelinghuys P. Siglecs as positive and negative regulators of the immune system. Biochemical Society Transactions 2008, 36:1467-1471.
5. Frankola K.A., Greig N.H., Luo W., Tweedie D. Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS and Neurological Disorders Drug Targets 2011, 10:391-403.
6. Gonzalez Y., Herrera M.T., Soldevila G., Garcia-Garcia L., Fabian G., Perez-Armendariz E.M., Bobadilla K., Guzman-Beltran S., Sada E., Torres M. High glucose concentrations induce TNF-alpha production through the down-regulation of CD33 in primary human monocytes. BMC Immunology 2012, 13:19.
7. Griciuc A., Serrano-Pozo A., Parrado A.R., Lesinski A.N., Asselin C.N., Mullin K., Hooli B., Choi S.H., Hyman B.T., Tanzi R.E. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 2013, 78:631-643.
8. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P.G., Hooper N.M., Vardy E.R., Hardy J., Mead S., Fox N.C., Rossor M., Collinge J., Maier W., Jessen F., Ruther E., Schurmann B., Heun R., Kolsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Gallacher J., Hull M., Rujescu D., Giegling I., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., van Duijn C.M., Breteler M.M., Ikram M.A., DeStefano A.L., Fitzpatrick A.L., Lopez O., Launer L.J., Seshadri S., Berr C., Campion D., Epelbaum J., Dartigues J.F., Tzourio C., Alperovitch A., Lathrop M., Feulner T.M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., Snaedal J., Bjornsson S., Jonsson P.V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M.J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossu P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P.A., Jonsson T., Riemenschneider M., Morgan K., Younkin S.G., Owen M.J., O'Donovan M., Amouyel P., Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics 2011, 43:429-435.
9. Jiang T., Yu J.T., Hu N., Tan M.S., Zhu X.C., Tan L. CD33 in Alzheimer's disease. Molecular Neurobiology 2013, 10.1007/s12035-013-8536-1.
10. Kim S.M., Song J., Kim S., Han C., Park M.H., Koh Y., Jo S.A., Kim Y.Y. Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. BMC Neurology 2011, 11:51.
11. Lacombe F., Durrieu F., Briais A., Dumain P., Belloc F., Bascans E., Reiffers J., Boisseau M.R., Bernard P. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 1997, 11:1878-1886.
12. Lajaunias F., Dayer J.M., Chizzolini C. Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling. European Journal of Immunology 2005, 35:243-251.
13. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
14. Malik M., Simpson J.F., Parikh I., Wilfred B.R., Fardo D.W., Nelson P.T., Estus S. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing. Journal of Neuroscience 2013, 33:13320-13325.
15. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
16. Morgan K. The three new pathways leading to Alzheimer's disease. Neuropathology and Applied Neurobiology 2011, 37:353-357.
17. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., St George-Hyslop P., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., DeKosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics 2011, 43:436-441.
18. Pillai S., Netravali I.A., Cariappa A., Mattoo H. Siglecs and immune regulation. Annual Review of Immunology 2012, 30:357-392.
19. Sun L., Tan M.S., Hu N., Yu J.T., Tan L. Exploring the value of plasma BIN1 as a potential biomarker for Alzheimer's disease. Journal of Alzheimer's Disease 2013, 37:291-295.
20. Swardfager W., Lanctot K., Rothenburg L., Wong A., Cappell J., Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biological Psychiatry 2010, 68:930-941.
21. Tan L., Yu J.T., Zhang W., Wu Z.C., Zhang Q., Liu Q.Y., Wang W., Wang H.F., Ma X.Y., Cui W.Z. Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population. Alzheimer's and Dementia 2013, 9:546-553.
22. Tan M.S., Yu J.T., Jiang T., Zhu X.C., Guan H.S., Tan L. IL12/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice. Journal of Alzheimer's Disease 2014, 38:633-646.
23. Tan M.S., Yu J.T., Jiang T., Zhu X.C., Tan L. The NLRP3 inflammasome in Alzheimer's disease. Molecular Neurobiology 2013, 48:875-882.
24. Tan M.S., Yu J.T., Jiang T., Zhu X.C., Wang H.F., Zhang W., Wang Y.L., Jiang W., Tan L. NLRP3 polymorphisms are associated with late-onset Alzheimer's disease in Han Chinese. Journal of Neuroimmunology 2013, 265:91-95.
25. Yu J.T., Song J.H., Wang N.D., Wu Z.C., Zhang Q., Zhang N., Zhang W., Xuan S.Y., Tan L. Implication of IL-33 gene polymorphism in Chinese patients with Alzheimer's disease. Neurobiology of Aging 2012, 33:e1011-e1014. 1014.
26. Yu J.T., Tan L., Song J.H., Sun Y.P., Chen W., Miao D., Tian Y. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Research 2009, 1253:169-175.
27. Zhang W., Wang L.Z., Yu J.T., Chi Z.F., Tan L. Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease. Journal of the Neurological Sciences 2012, 315:67-71.